Provided by Tiger Trade Technology Pte. Ltd.

Sight Sciences, Inc.

8.05
-0.0500-0.62%
Volume:167.16K
Turnover:1.35M
Market Cap:443.46M
PE:-14.47
High:8.24
Open:8.01
Low:7.90
Close:8.10
52wk High:9.24
52wk Low:3.19
Shares:55.09M
Float Shares:37.29M
Volume Ratio:1.09
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5564
EPS(LYR):-0.7369
ROE:-48.42%
ROA:-10.84%
PB:8.38
PE(LYR):-10.92

Loading ...

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

GlobeNewswire
·
Sep 02

Sight Sciences TearCare Wins FDA Label Expansion to Improve Meibomian Gland Function in Dry Eye Patients

Reuters
·
Aug 19

Sight Sciences Names Rashid Kashif as Chief Legal Officer in Initial Beneficial Ownership Filing

Reuters
·
Aug 19

Sight Sciences Earnings Call Shows Growth And Discipline

TIPRANKS
·
Aug 18

Sight Sciences price target raised to $8 from $6 at Citi

TIPRANKS
·
Aug 17

Citi Remains a Hold on Sight Sciences (SGHT)

TIPRANKS
·
Aug 14

Sight Sciences Names Kashif Rashid Chief Legal Officer, Replacing Jeremy Hayden

Reuters
·
Aug 10

Sight Sciences is Maintained at Buy by UBS

Dow Jones
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sight Sciences (SGHT)

TIPRANKS
·
Aug 07

UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating

MT Newswires Live
·
Aug 06

Tarsus Pharmaceuticals Q2 Sales Beat Estimates, Lifts 2026 Xdemvy Sales Outlook

Reuters
·
Aug 06

Germany's Carl Zeiss Meditec 9-Month Revenue Falls 2.9%

Reuters
·
Aug 06

Sight Sciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Sight Sciences Publishes Investor Presentation on Interventional Glaucoma, Dry Eye Platforms

Reuters
·
Aug 06

Sight Sciences Q2 2026 Earnings: Dry Eye Growth Supports Higher Revenue Guidance

TradingKey
·
Aug 06

Sight Sciences Q2 Revenue Rises 20%, Beats Estimates

Reuters
·
Aug 06

Sight Sciences Q2 EPS $(0.08) Beats $(0.15) Estimate, Sales $23.388M Beat $21.682M Estimate

Benzinga Earnings
·
Aug 06

Sight Sciences Q2 Revenue USD 23.4 Million Vs. IBES Estimate USD 21.7 Million

Reuters
·
Aug 06

Sight Sciences Q2 EPS USD -0.08

THOMSON REUTERS
·
Aug 06

Sight Sciences Outlook FY REV $88 Million to $92 Million

THOMSON REUTERS
·
Aug 06